Lux Health Techcquisition Corp. Class A (LUXA) Financials

$10.04

$0.00 (0.00%)

As on 04-Nov-2022 09:30EDT

Market cap

$433 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

21.8

P/B Ratio

1.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Operating Expenses	0.82	0.98	0.18	--	--	--
Operating Profit (EBIT)	-1.12	-1.18	-0.25	--	--	--
Other Income	--	--	--	--	--	--
Profit before Tax	19.82	27.10	-0.24	--	--	--
Provision for Tax	0.03	--	--	--	--	--
Profit after Tax (Net Income)	19.79	27.10	-0.24	--	--	--
Minority Interest	--	--	--	--	--	--
Consolidated Profit	19.79	27.10	-52.28	--	--	--

Liabilities ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Shareholder's Funds	-15.23	-27.49	333.83	--	--	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	14.69	27.24	12.08	--	--	--
Current Liabilities	1.20	0.92	0.19	--	--	--
Total Liabilities	1.85	345.68	346.09	--	--	--

Assets ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Non-Current Assets	345.53	345.03	345.00	--	--	--
Current Assets	0.15	0.65	1.09	--	--	--
Total Assets	346.88	0.68	346.09	--	--	--
Total Debt*	--	--	--	--	--	--
Net Current Assets	-1.05	-0.27	0.90	--	--	--

Cashflow ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Cash From Operating Activities	--	0.00	-0.58	--	--	--
Cash Flow from Investing Activities	--	--	-1,035.00	--	--	--
Cash from Financing Activities	--	0.00	346.22	--	--	--
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Adjusted EPS ($)	2.20	3.01	--	--	--	--
Cash EPS ($)	--	3.01	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	0.00	--	--	--	--
Free Cash Flow per Share ($)	--	0.00	--	--	--	--

Profitability Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
ROCE (%)	--	17.69	--	--	--	--
ROE (%)	--	17.69	--	--	--	--
ROA (%)	5.71	7.83	--	--	--	--
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	-34.09	-376.28	--	--	--	--
Net Profit Growth (%)	2.37	11,172.71	--	--	--	--
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	-104.91	--	--	--	--	--

Valuation Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Price / Earnings	21.85	3.25	--	--	--	--
Price / Book Value	1.31	-3.21	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-387.18	--	--	--	--	--
Close Price ($)	9.89	9.80	10.75	--	--	--
High Price ($)	10.12	13.27	12.09	--	--	--
Low Price ($)	9.68	9.68	10.30	--	--	--
Market Cap ($ Cr)	433.41	--	--	--	--	--

Solvency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debt to Equity	--	--	--	--	--	--
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	0.13	0.71	5.71	--	--	--
Quick Ratio	0.13	--	--	--	--	--
Interest Coverage	--	--	--	--	--	--

Operating Efficiency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.